Search Count: 114
 |
Hiv-1 Capsid (M-Group) - Native In Complex With Jw3-093
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2026-08-19 Classification: VIRAL PROTEIN Ligands: IOD, CL, BME, A1JMD |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2026-08-19
Ligands: IOD, CL, BME, A1JMD
 |
Hiv-1 Capsid (M-Group) - Cpsf6
Organism: Human immunodeficiency virus type 1 (new york-5 isolate), Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2026-08-12 Classification: VIRAL PROTEIN Ligands: IOD, CL, GOL |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate), Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-08-12
Ligands: IOD, CL, GOL
 |
Hiv-1 Capsid (M-Group) - Nup153
Organism: Human immunodeficiency virus type 1 (new york-5 isolate), Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2026-08-12 Classification: VIRAL PROTEIN Ligands: IOD, CL |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate), Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-08-12
Ligands: IOD, CL
 |
Hiv-1 Capsid (M-Group) - Native In Complex With Jw3-076
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2026-08-12 Classification: VIRAL PROTEIN Ligands: A1JL3, IOD, CL, BME |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2026-08-12
Ligands: A1JL3, IOD, CL, BME
 |
Hiv-1 Capsid (M-Group) - Native In Complex With Jw3-094
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION Resolution:2.36 Å Release Date: 2026-08-12 Classification: VIRAL PROTEIN Ligands: IOD, CL, BME, A1JL4 |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2026-08-12
Ligands: IOD, CL, BME, A1JL4
 |
Hiv-1 Capsid (M-Group) - Native In Complex With Jw3-134
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2026-08-12 Classification: VIRAL PROTEIN Ligands: IOD, CL, BME, 1PG, A1JL6 |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2026-08-12
Ligands: IOD, CL, BME, 1PG, A1JL6
 |
Hiv-1 Capsid (M-Group) - Native
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2026-07-08 Classification: VIRAL PROTEIN Ligands: IOD, CL, BME |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2026-07-08
Ligands: IOD, CL, BME
 |
Gag Ca-Sp1 Immature Lattice Bound With Lenacapavir From Enveloped Virus Like Particles
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: ELECTRON MICROSCOPY Resolution:2.28 Å Release Date: 2026-04-29 Classification: VIRUS LIKE PARTICLE Ligands: QNG, IHP |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: ELECTRON MICROSCOPY
Release Date: 2026-04-29
Ligands: QNG, IHP
 |
Ca-Sp1 Immature Lattice Assembled In Vitro With Inhibitor Lenacapavir (Dialyzed To 50Nm)
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: ELECTRON MICROSCOPY Resolution:2.93 Å Release Date: 2026-04-29 Classification: VIRUS LIKE PARTICLE Ligands: QNG, IHP |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: ELECTRON MICROSCOPY
Release Date: 2026-04-29
Ligands: QNG, IHP
 |
Hiv Ca - Glfg Peptide (4 Mm)
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN |
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
 |
Hiv Ca - Glfg Peptide (9 Mm)
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN Ligands: CL |
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: CL
 |
Hiv Ca - Glfg Peptide (43 Mm)
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN Ligands: CL |
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: CL
 |
Hiv Ca - Fsfg Peptide (14 Mm)
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.99 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN Ligands: CL |
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: CL
 |
Hiv Ca - Fg Peptide (14 Mm)
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN Ligands: CL |
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: CL
 |
Hiv Ca - Fg Peptide (34 Mm)
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN Ligands: CL |
Organism: Human immunodeficiency virus type 1, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: CL
 |
Hiv-1 Integrase Core Domain In Complex With Potent Allosteric Inhibitors
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-12-31 Classification: VIRAL PROTEIN Ligands: A1MCX, 1PE, SO4 |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2025-12-31
Ligands: A1MCX, 1PE, SO4
 |
Immature Hiv-1 Cactd-Sp1 Lattice With Maturation Inhibitor Pf-46396 (R) And Inositol Hexakisphosphate (Ip6)
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: SOLID-STATE NMR Release Date: 2025-10-08 Classification: PROTEIN BINDING Ligands: IHP, A1CCY |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: SOLID-STATE NMR
Release Date: 2025-10-08
Ligands: IHP, A1CCY
 |
Immature Hiv-1 Cactd-Sp1 Lattice With Maturation Inhibitor Pf-46396 (R) And Inositol Hexakisphosphate (Ip6)
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: SOLID-STATE NMR Release Date: 2025-10-08 Classification: PROTEIN BINDING Ligands: A1CCY, IHP |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: SOLID-STATE NMR
Release Date: 2025-10-08
Ligands: A1CCY, IHP
 |
Immature Hiv-1 Cactd-Sp1 Lattice With Maturation Inhibitor Pf-46396 (S) And Inositol Hexakisphosphate (Ip6)
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: SOLID-STATE NMR Release Date: 2025-10-08 Classification: PROTEIN BINDING Ligands: IHP, A1CCZ |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: SOLID-STATE NMR
Release Date: 2025-10-08
Ligands: IHP, A1CCZ
 |
Immature Hiv-1 Cactd-Sp1 Lattice With Maturation Inhibitor Pf-46396 (S) And Inositol Hexakisphosphate (Ip6)
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: SOLID-STATE NMR Release Date: 2025-10-08 Classification: PROTEIN BINDING Ligands: IHP, A1CCZ |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: SOLID-STATE NMR
Release Date: 2025-10-08
Ligands: IHP, A1CCZ